Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yonghe Medical Group CoFRA:L97 -1.53%84 PS Ratio is 0.54 as of Aug. 21, 2026, which is 7% below its 10-year median of 0.58. GuruFocus rates FRA:L97 with a GF Score™ of 84/100 and a GF Value™ of €0.21. The stock has 7 warning signs investors should review. Among 656 Healthcare Providers & Services companies, Yonghe Medical Group Co ranks better than 75.61% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Yonghe Medical Group Co's share price is €0.258.
Yonghe Medical Group Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was €0.48. Hence, Yonghe Medical Group Co's PS Ratio for today is 0.54.
The historical rank and industry rank for Yonghe Medical Group Co's PS Ratio or its related term are showing as below:
FRA:L97'
s PS Ratio Range Over the Past 10 Years
Min: 0.17 Med: 0.58 Max: 4.71
Current: 0.57
During the past 8 years, Yonghe Medical Group Co's highest PS Ratio was 4.71. The lowest was 0.17. And the median was 0.58.
FRA:L97's PS Ratio is ranked better than 75.61% of 656
companies
in the Healthcare Providers & Services industry
Industry Median: 1.545
vs FRA:L97: 0.57
During the past 8 years, Yonghe Medical Group Co's highest 3-Year average Revenue per Share Growth Rate was 44.60% per year. The lowest was -14.60% per year. And the median was 5.50% per year.
Yonghe Medical Group Co (FRA:L97) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Yonghe Medical Group Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yonghe Medical Group Co PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yonghe Medical Group Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Yonghe Medical Group Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Yonghe Medical Group Co's Share Price of today is €0.258.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Yonghe Medical Group Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was €0.48.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Yonghe Medical Group Co (FRA:L97) has a PS Ratio of 0.54 as of Aug. 21, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Yonghe Medical Group Co and its competitors. This is near median its historical median of 0.58. Over the past decade, Yonghe Medical Group Co's PS Ratio has ranged from 0.17 to 4.71. According to the industry distribution chart, Yonghe Medical Group Co ranks #160 out of 656 companies in the Healthcare Providers & Services industry, placing it in the top 24.4%.
Is Yonghe Medical Group Co's PS Ratio too high?
Yonghe Medical Group Co's current PS Ratio of 0.54 is near median its 10-year median of 0.58. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 4.71. The Healthcare Providers & Services industry median PS Ratio is 1.55. Yonghe Medical Group Co's value of 0.54 is 65% below this industry median. Based on the distribution chart, Yonghe Medical Group Co ranks #160 out of 656 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Yonghe Medical Group Co has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Yonghe Medical Group Co's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Yonghe Medical Group Co ranks #160 out of 656 companies for PS Ratio. This places Yonghe Medical Group Co in the top 24% of its industry — outperforming the majority of peers. The industry median PS Ratio is 1.55. Yonghe Medical Group Co's value of 0.54 is 65% below this benchmark. Historically, Yonghe Medical Group Co's own PS Ratio has ranged from 0.17 to 4.71 over the past decade. While the company's 10-year median is 0.58 vs. the industry median of 1.55, Yonghe Medical Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.55, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yonghe Medical Group Co's current PS Ratio of 0.54 is 65% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Yonghe Medical Group Co and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yonghe Medical Group Co's current PS Ratio is 0.54, which is near median its own 10-year median of 0.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yonghe Medical Group Co stock overvalued right now?
Yonghe Medical Group Co (FRA:L97) has a current PS Ratio of 0.54. The stock's GF Value™ is €0.21, compared to a current price of €0.26 — trading 22.9% above its estimated fair value. The current PS Ratio is 0.54, which is near median its 10-year median of 0.58 and 65% below the Healthcare Providers & Services industry median of 1.55. Yonghe Medical Group Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Yonghe Medical Group Co (FRA:L97), the current PS Ratio is 0.54 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yonghe Medical Group Co (FRA:L97) Overvalued in 2026?
Based on GuruFocus' analysis, Yonghe Medical Group Co stock appears to be overvalued.
The current stock price of €0.26 is trading 22.9% above its estimated GF Value™ of €0.21.
Key valuation signals for FRA:L97:
PS Ratio: 0.54 (near median its 10-year median of 0.58)
GF Value™: €0.21 vs. price of €0.26 (22.9% above fair value)
Industry Position: 65% below the Healthcare Providers & Services median (#160 of 656)
No single metric tells the full story. See the FRA:L97 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. The company is principally engaged in the provision of hair transplant services. The company generated the majority of its revenue from hair transplant services. The company offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
84GF Score
Get the complete analysis for FRA:L97
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L97 has been successfully added to your 
